PE & DVT dx tool vs CV Risk Estimation

The gold standard diagnostic tests for DVT and PE are invasive venography and invasive pulmonary angiography (and autopsy). These tests are invasive, time consuming, technically challenging, and sometimes not feasible for a highly ill patient. No single alternative test alone is quicker, easier, less invasive, and as accurate. But combinations of tests starting with clinical scoring systems for pretest probability followed by sequential labwork and imaging can almost always do the job. The only problem is that the algorithms involved are very hard to memorize and keep straight. That's where a point-of-care guide like this comes in. The app offers 1 algorithm for DVT diagnosis and 2 algorithms for PE diagnosis, as well as discussion of diagnostic approach and workup of hypercoagulable state. The app addresses such common questions as: * what are the Wells clinical criteria and scoring systems for DVT and PE? * in which situations will a D-dimer alone rule out DVT? how about PE? * how can I use the rarely definitive VQ scan to diagnose PE, and what other tests might I need to use along with it? * how can I safely and effectively evaluate for PE in a pregnant patient? This app is written and intended for practicing clinicians like internists, hospitalists, family physicians, obstetricians, ER and urgent care docs; for resident physician trainees; and for medical students. As an educator and clinician, I am interested in feedback and I would be grateful for guidance on improving the tool.

This app is for CLINICIANS, not the lay public. The CV Risk app presents clinicians with three valuable 10-year cardiovascular event risk calculators to serve clinicians and learners in primary prevention of cardiovascular disease. It is for clinicians only, not the lay public. The calculators are Framingham 2008, ASCVD 2013, and the revised pooled cohort equations ASCVD of 2018. The app addresses such common questions as: • What is the ASCVD 10-year CV risk for a 57 year old male hypertensive smoker with a given set of lipid and blood pressure numbers? • What’s the magnitude of impact of a patient on their own improving their cholesterol by 11, 27, or 41 points? • For a poorly controlled hypertensive smoker with a 10-year risk of 31.3%, how impactful would improved blood pressure control or smoking cessation be? • How impactful is a cholesterol of 220 on a given patient's risk at 35 vs. 55 vs. 75 years old? • I hear that ASCVD 2013 overestimates risk, particularly for black adults? True? What about the revised pooled cohort equations of 2018? The app explicitly does not include treatment thresholds, LDL targets, estimates of impact of therapy, coronary calcium scoring, etc. I wanted the cleanest simplest tool possible for evaluating and discussing cardiovascular risk with all the other more subjective, controversial stuff out of the way. This app is written and intended for practicing clinicians like internists and family physicians; for resident physician trainees; for medical students; and of course for other clinician colleagues like NP's and PA's. Cardiologists could use this app, but you folks are focused on secondary prevention, which is an entirely different ballgame. As an educator and clinician, I am interested in feedback and I would be grateful for guidance on improving the tool.